Abstract
The Foundation for Opioid Response Efforts (FORE), a national grant‐making organization, in a March 9 webinar focused on access to treatment to buprenorphine. FORE recognized early on (when it launched its grant‐making 3 years ago) that removing the X‐waiver may not increase access to treatment. The X‐waiver was removed, and the next step is to increase access to treatment, according to webinar participants.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Brown University Child & Adolescent Psychopharmacology Update
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
